Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is vasoactive intestinal polypeptide (VIP) a sleep factor?

R Drucker-Colín, J Bernal-Pedraza, F Fernández-Cancino

    Peptides
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Total durations of respiratory events are modulated within REM and NREM sleep by sleeping position and obesity in OSA patients.

    Sleep medicine·2021
    Same author

    Standardized framework to report on the role of sleeping position in sleep apnea patients.

    Sleep & breathing = Schlaf & Atmung·2021
    Same author

    Polysomnographic characteristics of severe obstructive sleep apnea vary significantly between hypertensive and normotensive patients of both genders.

    Sleep & breathing = Schlaf & Atmung·2020
    Same author

    Retracted: Hypocretin (orexin) cell transplantation diminishes narcoleptic-like sleep behavior in rats.

    CNS & neurological disorders drug targets·2012
    Same author

    Neuroprotective effects of extremely low-frequency electromagnetic fields on a Huntington's disease rat model: effects on neurotrophic factors and neuronal density.

    Neuroscience·2012
    Same author

    Fetal substantia nigra and adrenal medullary grafts placed contralateral to the nigrostriatal lesion side induce a decrease in turning behavior but not in dopamine receptor density.

    Restorative neurology and neuroscience·2011
    Same journal

    Potential role of intelectin-1 in the regulation of feeding of goldfish (Carassius auratus).

    Peptides·2026
    Same journal

    Cocaine- and amphetamine-regulated transcript (CART) peptides: Neuroanatomical distribution and functional implications in the mammalian central nervous system.

    Peptides·2026
    Same journal

    P1642-1, a novel pancreatic polypeptide analogue, ameliorates cognitive impairment in 5 ×FAD mice and is associated with enhanced PINK1/Parkin-related mitophagy.

    Peptides·2026
    Same journal

    Structure-based rational design of high-affinity JAZF1 variants peptides to target the testicular orphan nuclear receptor 4 and pro-opiomelanocortin axis in Cushing's disease.

    Peptides·2026
    Same journal

    [Gly<sup>2</sup>]-GLP-2(1-5): An ultra-short GLP-2 peptide for intestinal mucosal protection in inflammatory bowel disease.

    Peptides·2026
    Same journal

    The role of Kiss1 neurons in regulating metabolism and energy balance.

    Peptides·2026
    See all related articles

    Vasoactive intestinal peptide (VIP) slightly enhanced REM sleep in cats but did not counteract REM suppression from chloramphenicol (CAP). These findings suggest VIP

    Area of Science:

    • Neuroscience
    • Sleep Science
    • Pharmacology

    Background:

    • Vasoactive intestinal peptide (VIP) is a neuropeptide with diverse physiological roles.
    • Its potential involvement in sleep regulation, particularly REM sleep, remains incompletely understood.

    Purpose of the Study:

    • To investigate the hypnogenic (sleep-inducing) properties of VIP in feline models.
    • To determine if VIP influences REM sleep and its susceptibility to disruption by chloramphenicol (CAP).

    Main Methods:

    • Intraventricular administration of VIP (10 and 100 ng) or Ringer controls in cats.
    • Testing of 100 ng VIP in cats pretreated with chloramphenicol (CAP), a known REM sleep inhibitor.

    Main Results:

    • A 100 ng dose of VIP demonstrated a small but statistically significant enhancement of REM sleep.

    Related Experiment Videos

  • VIP did not prevent or reverse the REM sleep-inhibiting effects of CAP.

    • Conclusions:

    • VIP may play a role in the endogenous regulation of REM sleep.
    • The REM-enhancing effects of VIP are distinct from its ability to counteract CAP-induced REM suppression.